Genpact speeds pivot to Data & AI with XponentL buy, Q2 revenue, EPS up amid rising debt risks

Genpact Limited (NYSE: G) - Quick read (figures per 10‑Q, amounts in thousands)

What's happening inside the company
- Management is accelerating the pivot into data & AI: closed the XponentL acquisition (announced June 5, 2025) to add data/AI engineering and go‑to‑market capability (purchase consideration $159,811; earn‑out recorded $77,500).
- Headcount is growing to support that shift: average headcount ~146,900 in Q2 2025 (up 9.9% YoY).
- Capital allocation remains shareholder friendly: dividend up (Q2 dividend $0.17/share; six‑month dividends $59,408) and active buybacks (1,898,010 shares repurchased in H1 2025 for $92,961; $554,045 remaining authorization as of 6/30/2025).
- Balance sheet movements: cash & cash equivalents $663,260; accounts receivable net $1,266,653; total assets $5,307,680; total liabilities $2,721,069; total equity $2,586,611.

Key financial highlights (selected)
- Net revenues Q2 2025: $1,254,418 (vs. $1,176,212 Q2 2024) - +6.6% YoY.
- Net revenues YTD (six months) 2025: $2,469,344 (vs. $2,307,449) - +7.0% YoY.
- Gross profit Q2 2025: $450,068; gross margin Q2 2025: 35.9% (up from 35.4%).
- Income from operations Q2 2025: $179,402 (vs. $170,251).
- Net income Q2 2025: $132,716 (vs. $121,990); diluted EPS Q2 2025: $0.75 (vs. $0.67).
- Adjusted income from operations (AOI) Q2 2025: $217,300 (up from $198,400) - AOI margin 17.3% vs. 16.9% prior year.
- Operating cash flow (six months): $217,801 (vs. $183,713).
- Short‑term borrowings as of 6/30/2025: $85,000; current portion of long‑term debt: $375,714; total long‑term debt (net) $1,209,087.
- Allowance for credit losses on AR rose to $26,830 (from $12,094 at year‑end 2024).

Positive aspects of the income statement and operations
- Revenue growth across the business: +6.6% Q2 and +7.0% YTD, with Data‑Tech‑AI and Advanced Technology Solutions showing faster expansion (Data‑Tech‑AI Q2 +9.7%; Advanced Technology Solutions Q2 +17.3%).
- Margin improvement: gross margin increased to 35.9% and AOI margin expanded to 17.3% - indicates operating leverage as revenue scales.
- Profitability and EPS up: net income +8.8% YoY in Q2 and diluted EPS improved from $0.67 to $0.75.
- Strong operating cash generation: operating cash flow increased to $217.8M in H1 2025, supporting acquisitions, dividends and buybacks.
- Strategic M&A: XponentL acquisition directly supports the AI/data strategy and brings immediate intangible assets and goodwill aligned to growth areas.

Negative aspects / risks visible in the income statement and balance sheet
- SG&A growth: SG&A up 11.2% YoY in Q2 (SG&A as % of revenue rose from 20.4% to 21.2%) - spending on sales, partnerships and support is pressuring operating leverage despite gross margin gains.
- Credit quality and working capital strain: allowance for credit losses on receivables more than doubled (12,094 → 26,830), and accounts receivable increased to $1,266,653 - higher credit provisions and receivables could pressure cash conversion.
- Higher near‑term leverage: current portion of long‑term debt jumped to $375,714 (reflects scheduled near‑term maturities / term loan amortization profile) and short‑term borrowings of $85,000 increased liquidity usage.
- Acquisition contingent liability: earn‑out fair value $77,500 (level 3) creates contingent cash obligations tied to future performance.
- Rising stock‑based comp and other non‑cash costs: stock‑based compensation increased (six months 2025: $41,834) which reduces reported margins and increases dilution risk over time.
- Investing cash use: H1 investing cash outflow widened to $104,420 primarily due to acquisition payments ($80,621), reducing free cash available for other uses in the near term.

Segment and product highlights
- Data & AI traction: Data‑Tech‑AI revenue Q2 2025 $599,265 (+9.7% YoY); Advanced Technology Solutions revenue Q2 2025 $292,655 (+17.3% YoY).
- Core Business Services / Digital Operations still the largest bucket (Core Business Services Q2 2025 $961,763), showing steady mid‑single digit growth - mix shift to higher‑growth tech offerings is underway but Core remains material to margins.

Watchlist / near‑term catalysts and risks
- Debt maturities and interest cost: 2021 Senior Notes $349,532 due April 10, 2026; term loan amortization and covenant compliance (leverage <3x) are items to monitor.
- Earn‑out payment timing: $77,500 contingent earn‑out payable March 2026 - cash planning required.
- Receivables & credit losses: rising allowance and AR balances - monitor DSO, collection trends and concentration risk.
- Integration of XponentL and realization of synergies: execution risk on converting acquisition into growth and accretive results.
- Macro & FX: management calls out macro/geopolitical uncertainty and FX volatility; hedging activity is in place but remains a source of earnings variability.

Bottom line
Genpact (NYSE: G) is executing its data‑and‑AI growth strategy: revenues and margins are moving in the right direction, operating cash flow is solid, and management continues to return capital to shareholders. That said, rising SG&A, increased credit provisions, near‑term debt cash requirements and a material contingent earn‑out introduce execution and liquidity risks to watch over the next 12 months. Investors should track receivables trends, the March 2026 earn‑out/debt profile, and whether new AI investments convert into sustained higher‑margin revenue.

Source: Genpact Limited Form 10‑Q for quarter ended June 30, 2025 (figures and captions quoted from the filing).